Neuland Laboratories Ltd (NEULANDLAB)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 14418.00
% Change: -0.22% (Prev Close: 14450.00)

Volume: 16,152
% Change: -58.31% (Prev Volume: 38,746)

Delivery: 5,867
Delivery % : 36.32
% Change: -64.07% (Prev Delivery: 16,328)

Turnover: 2,330 Lacs
% Change: -58.22% (Prev Turnover: 5,575)

πŸ’Ή EOD Valuation

P/E Ratio: 105.02
P/B Ratio: 12.13
Market Cap: 18455 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: NEULANDLAB
Market Cap: 17263 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 18100.00
52 Week Low: 10060.00

All-Time High: 18100.00 Rs.
All-Time Low: 51.72 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
12.00% | 10.27% | 18.80% | 13.10% | 127.72%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 32.68%

Change (3Y | 1Y): -3.54% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 21.69%

Change (3Y | 1Y): 4.30% | -0.43%

DII Holding

DII Holding: 11.57%

Change (3Y | 1Y): 5.12% | 0.60%

Public Holding: 33.67%

🏦 Financial Strength

Debt to Equity: 0.10
Debt: 157.14 Rs. Cr.

Book Value: 1188.48 Rs.
Current Ratio: 2.22
Interest Coverage: 18.46
Free Cash Flow: 112.08 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: -18.67%

Sales Growth Qtr (YOY | QoQ):
-33.41% | -10.84%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
14.13% | 15.80% | -18.67%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: -58.88%

Profit Growth Qtr (YOY | QoQ):
-83.11% | -50.02%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
66.88% | 47.28% | -58.88%

EPS Rs.

EPS (TTM): 137.29 Rs.

EPS Qtr (Last Year | Latest):
76.28 Rs. | 10.83 Rs.

EPS Annual (Last Annual | Annual March):
233.89 Rs. | 202.74 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
66.88% | 47.28%

Net Profit Rs. Cr.

Net Profit (TTM): 176.14 Rs. Cr.

Net Profit (Annual - March): 260.11 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
97.87| 27.81 | 13.90

EBITDA Rs. Cr.

EBITDA (Quarter): 42.34 Rs. Cr.
EBITDA (Previous Yr Ql): 128.16 Rs. Cr.

EBITDA (Annual - March): 351.09 Rs. Cr.
EBITDA (Previous Annual): 475.54 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
27.21% | 33.82%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 17.62%

OPM Qtr (Previous | Current):
15.56% | 11.78%

OPM Annual (5 Yrs | Last Yr | March):
22.21% | 29.71% | 22.38%

Return on Equity %

ROE: 14.83%

ROE (5 Yrs | 3 Yrs | Last Yr):
16.11% | 19.45% | 26.39%

Return on Capital Employed %

ROCE: 18.66%

ROCE (5 Yrs | 3 Yrs | Last Yr):
18.73% | 24.26% | 33.26%

Return on Assets %

ROA (TTM): 10.38%

ROA (5 Yrs | 3 Yrs | Last Yr):
9.88% | 13.02% | 17.61%

PEG Ratio: 2.77
Dividend Yield: 0.09%

PE 3 Yrs: 27.81
PE 5 Yrs: 29.08

Dividend Yield: 0.09%

πŸ‘₯ Company

Neuland Laboratories Ltd

NEULANDLAB

Promoter Holding: %